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Abstract 
In this study we present the results of the equilibrium, dissociation kinetics, DFT and X-ray crystallographic 
studies performed on the complexes of metal ions of biomedical importance (Mn
2+
, Cu
2+
 and Gd
3+
) formed 
with octadentate ligands based on a cyclen platform incorporating two picolinate pendant arms (dodpa
2−
 and 
Medodpa
2−
). The stability constants of the complexes were accessed by multiple methods (pH-potentiometry, 
direct and competition UV-vis spectrophotometry and 
1
H-relaxometry). The stability constants of the 
complexes formed with dodpa
2−
 and Medodpa
2−
do not differ significantly (e.g. log K[Mn(dodpa)] = 17.40 vs. log 
K[Mn(Medodpa)] = 17.46, log K[Cu(dodpa)] = 24.34–25.17 vs. log K[Cu(Medodpa)] = 24.74 and log K[Gd(dodpa)]
+
 = 17.27 vs. 
log K[Gd(Medodpa)]
+
 = 17.59), which indicates that the steric hindrance brought by the methyl groups has no 
significant effect on the stability of the complexes. The stability constants of the Mn
2+
 complexes formed 
with the cyclen dipicolinates were found to be ca. 3 log K units higher than those determined for the 
complex of the cyclen monopicolinate (dompa
−
), which indicates that the second picolinate moiety attached 
to the backbone of the macrocycle is very likely coordinated to the Mn
2+
 ion. However, the stability of the 
[Cu(dodpa)] and [Cu(Medodpa)] complexes agrees well with the stability constant of [Cu(dompa)]
+
, in line 
with the hexadentate coordination around the metal ion observed in the X-ray structure of [Cu(Medodpa)]. 
The [Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 complexes display a fairly high kinetic inertness, as the rate 
constants of acid catalysed dissociation (k1 = 2.5(4) × 10
−3
 and 8.3(4) × 10
−4
 M
−1
 s
−1
 for [Gd(dodpa)]
+
 and 
[Gd(Medodpa)]
+
, respectively) are smaller than the value reported for [Gd(do3a)] (k1 = 2.5 × 10
−2
 M
−1
 s
−1
). 
The [Mn(dodpa)] complex was found to be more inert than [Mn(Medodpa)]. The results of the diffusion 
ordered NMR spectroscopy (DOSY) and DFT calculations of diamagnetic [La(dodpa)]
+
 and 
[Lu(dodpa)]
+
 complexes indicate the formation of a trinuclear entity of the La complex in aqueous solution. 
Keywords: cyclen-based ligands; lanthanide complexes; crystal structures; transition-metal complexes; 
picolinate pendants 
 
 
Introduction 
Complexes formed with polyaza-polycarboxylate ligands and their derivatives containing amide, 
phosphinate, phosphonate or alcohol OH moieties have attracted considerable attention in recent years due to 
their successful application in medical diagnosis and therapy. Complexes of open-chain and macrocyclic 
polyamines are now routinely used as carriers of radionuclides in Positron Emission Tomography (PET), 
Single Photon Emission Computed Tomography (SPECT), or RadioImmunoTherapy (RIT).
1
 Besides, 
complexes of paramagnetic metal ions such as Gd
3+
 are applied as contrast agents in Magnetic Resonance 
Imaging (MRI),
2
 while compounds containing an appropriate antenna in order to sensitize Ln
3+
luminescence 
have potential application in optical imaging.
3
 However, research in this field appears to be shifting towards 
the use of macrocyclic chelators owing to the favourable coordinating properties of these types of ligands. 
Indeed, the complexes considered for in vivo use must fulfil well defined requirements; among these, fine-
tuning of thermodynamics, kinetics (formation and dissociation) and redox stabilities through careful ligand 
design remains an important goal for coordination chemists. The complexes formed by macrocyclic ligands 
were often found to be very inert even in competitive biological media (containing proteins, bioligands, 
biogenic metal ions, etc.), but they are also known to form more slowly.
4
 Thus, tailoring new ligands with 
improved complexation properties for various applications is still very challenging. 
Designing ligands for biomedical applications requires the selection of ligand structures, allowing for a 
specific functionalization of the backbone (i.e. C- or N-functionalized ligands). This allows obtaining, for 
instance, more rigid (and more inert) complexes or producing bifunctional chelating agents (BCAs), which 
contain a chemically reactive group suitable for linking the complexes to their carriers, vectors, etc.
5
 Another 
important point in the ligand design is the proper selection of the pendant arms to be used, as it may affect 
considerably the physicochemical properties of the complexes (stability, inertness, redox potential, etc.) or 
can act as a built-in chromophore capable of efficient Ln
3+
 sensitization.
6
 In this respect, the 
pyridinecarboxylate (picolinate) moiety is a very versatile building block, as it has been shown to provide 
strong coordination toward different metal ions (Mn
2+
, Cu
2+
 and Ln
3+
 ions) when attached to both linear and 
macrocyclic platforms.
7–10
 Indeed, in the last ten years, ligands incorporating one, two or three 
pyridinecarboxylate units derived from open chain (iminodiacetic (imda
2−
), nitrilotriacetic (nta
3−
), 
ethylenediamine-tetraacetic (edta
4−
) and trans-1,2-diaminocyclohexane-N,N,N′,N′-tetraacetic (tcdta4−) acids), 
as well as macrocyclic polyamines (based on 1,4,7-triazacyclononane, 1,4,7,10-tetraazacyclododecane, 
1,4,8,11-tetraazacyclotetradecane along with their cross-bridged derivatives) were prepared and their 
complexes characterized in solution and in the solid state.
7–9
 As a result of the intense research on this topic, 
different ligands containing picolinate groups were shown to provide: (1) Ln
3+
 complexes endowed with 
remarkably high thermodynamic stability and satisfactorily high inertness,
11
 (2) excellent selectivity for the 
lighter Ln
3+
 ions over the heavier ones (allowing us to develop separation procedures for lanthanide(III) and 
actinide(III) ions),
12
 (3) efficient sensitization of Eu
3+
 and Tb
3+
 luminescence,
6,11
 or (4) Gd
3+
 complexes with 
very high water exchange rates.
8,13
 As mentioned before, certain applications require the attachment of a 
biomolecule (e.g. functionalization via the reactive group methodology) responsible for taxiing the 
chelates in vivo (BCAs). In this respect synthetic strategies showed that the 4-position of the pyridine ring of 
the picolinate moiety is easily accessible.
14
 
In recent studies, we have reported a series of octadentate ligands based on 12-membered macrocycles 
containing one or two pyridinecarboxylate units (do3a-pic
4−
, do3a-picOMe
4−
, bp12c4
2−
, dodpa
2−
 and 
Medodpa
2−
) designed for stable Ln
3+
 ion complexation in aqueous solution (Scheme 1).
9,11,15
 The 
Ln
3+
 complexes of these ligands were characterized both in solution (
1
H, 
13
C, and 
17
O NMR, DFT 
calculations, luminescence lifetime measurements) and in the solid state (X-ray crystallography). However 
data concerning the stability and inertness of their complexes are available only for some systems (do3a-
pic
4−
, do3a-picOMe
4−
 and bp12c4
2−
).
8,11
 Thus, the aim of the work reported here was to investigate the 
thermodynamic stability and kinetic inertness of the complexes formed by dodpa
2−
 and Medodpa
2−
 with 
 
 
some metal ions with potential biomedical interest (Mn
2+
, Cu
2+
 and Gd
3+
). Gd
3+
 and Cu
2+
 were chosen due to 
the importance of the complexes of these metal ions in MRI and PET imaging, respectively,
1,2
 while 
Mn
2+
 was selected due to the increasing recent effort reported in the literature to develop Mn
2+
-based MRI 
contrast agents.
16
 The equilibrium processes in these systems were characterized by pH-potentiometry, UV-
vis spectrophotometry and 
1
H-relaxometry. The kinetic inertness of the Mn
2+
 and Gd
3+
 complexes was 
accessed by studying respectively the metal exchange reactions occurring between the Mn
2+
 complexes and 
the Cu
2+
 ion and the acid catalysed dissociation for the [Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 complexes. The 
structure of the Medodpa
2−
 ligand and its monomeric Cu
2+
 complex was characterised by X-ray 
crystallography in the solid state, while diffusion-ordered spectroscopy (DOSY), Hartree–Fock (HF) and 
density functional theory (DFT) calculations were used to gain information about the unexpected self-
aggregation of the [La(Medodpa)]
+
 complex in aqueous solution. 
 
 
Scheme 1. Ligands discussed in the present work. 
 
 
Results and discussion 
Equilibrium studies: ligand protonation constants and stability constants of Mn
2+
, Cu
2+
 and Gd
3+
complexes 
The protonation constants of dodpa
2−
 and Medodpa
2−
 were determined by pH-potentiometric titrations; the 
constants and standard deviations are given in Table 1, which also lists the protonation constants of related 
ligands. Ligand protonation constants were calculated from the overall equilibrium constants (log
β01R where R = 1 to 6), as defined in eqn (1) and (2): 
 
  𝑃M + 𝑄L + 𝑅H ⇆ M𝑃L𝑄H𝑅      (1) 
 
  𝛽𝑃𝑄𝑅 =
[M𝑃H𝑄L𝑅]
[M]𝑃[H]𝑅[L]𝑄
      (2) 
 
Thus, the protonation constants of the ligands and complexes were calculated using the following equations: 
 
  𝐾𝑖
H =
[H𝑖L]
[H𝑖−1L][H+]
       (3)  
   
  𝐾MH𝑖L =
[MH𝑖L]
[MH𝑖−1L][H+]
      (4) 
 
The data shown in Table 1 indicate that the first protonation constants of dodpa
2−
 and Medodpa
2−
 are very 
similar, while the second protonation constant K
H
2 is ca. 1.2 units higher in dodpa
2−
. This result suggests that 
HMedodpa
−
 is stabilized by intramolecular hydrogen-bonding interactions. The first protonation constant is 
somewhat lower than that reported for do3a
3−
and dota
4−
,
17
 but similar to that determined for dompa
−
,
18
 which 
can be partially ascribed to the electron withdrawing effect of the picolinate pendant arm.
19
 Different studies 
on 1,4,7,10-tetraazacyclododecane derivatives have revealed that the first two protonation processes occur on 
nitrogen atoms of the macrocycle situated in a trans position. As stated earlier,
8
 the third and fourth 
protonation constants can be assigned to the picolinate moiety, while the fifth protonation process most 
likely occurs on a third nitrogen atom of the macrocycle. The first two protonation constants of dodpa
2−
 and 
Medodpa
2−
 are two log K units higher than those of the diaza-12-crown-4 derivative bp12c4
2−
. 
The X-ray crystal structure of the [H4Medodpa]
2+
 cation confirms the proposed protonation constant 
assignments (Fig. 1). Indeed, the two trans N atoms of the cyclen unit containing methyl substituents and the 
carboxylate groups of the ligand are protonated. In addition, the protonated N atoms are involved in 
hydrogen-bonding interactions with the N atoms of the pyridyl groups. The 12-membered macrocycle adopts 
a square [3333] conformation similar to that observed for protonated forms of dota
4−
 and related ligands,
20
 in 
which the ligand is predisposed to bind metal ions.  
 
 
 
 
Table 1. Protonation and stability constants characterizing the equilibrium involving the dodpa
2−
 and 
Medodpa
2−
 ligands as well as their Mn
2+
, Cu
2+
 and Gd
3+
 complexes (25 °C). 
 
 dodpa
a
 Medodpa
a
 do3a
a
 do3a
g
 dota
g
 dompa
h
 bp12c4
i
 
 0.15 M NaCl 0.15 M NaCl 0.15 M NaCl 0.1 M KCl 0.1 M KCl 0.15 M NaCl 0.1 M KCl 
Log K
H
1 11.16(1) 11.36(1) 10.07(5) 11.99 11.41 11.22 9.16 
Log K
H
2 10.11(1) 8.88(3) 8.93(6) 9.51 9.83 9.38 7.54 
Log K
H
3 4.06(2) 4.12(4) 4.43(9) 4.30 4.38 3.39 3.76 
Log K
H
4 3.50(3) 3.50(3) 4.11(7) 3.63 4.63  2.79 
Log K
H
5 0.90(2) 1.18(2) 1.88(7) 1.84 1.92   
Σlog KH4 28.83 27.86 27.54 29.43 30.25  23.25 
Log βMnL 17.33(1)
b
 17.42(1)
b
 16.76(2)  19.89 14.48  
 17.75(3)
c
 17.73(2)
c
      
Log βMnHL 21.20(4) 20.74(1) 20.70(2)  24.15 18.51  
Log βMnH2L   23.88(3)  27.14   
Log βCuL 24.34(5)
d
 24.74(2)
f
  25.75 22.25 24.0 19.56 
 24.44(3)
e
     25.06
e
  
 25.17(4)
f
       
Log βCuHL 29.63(5)
c
 30.18(2)
f
  29.4 26.03 25.83 26.08 
 29.74(3)
e
     26.92
e
  
 29.61(2)
f
       
Log KCuHL 5.27(4)
d
 5.58(8)
d
      
 5.29(5)
e
 5.38(6)
d
      
 5.30(3)
f
 5.44(9)
f
      
Log βCuH2L 31.49(5)
b
   31.09 29.08   
 31.64(3)
d
       
 31.62(2)
e
       
Log KCuH2L 1.91(4)
b
       
 2.01(3)
d
       
 1.88(2)
e
       
Log βGdL 17.27(16)
c
 17.59(12)
c
  21.56 24.0  18.82 
    21.1
g
    
Log βGdHL    23.16
g
 26.30   
 
a This work. b Obtained from potentiometric titrations. c Obtained from relaxometric data. dObtained with UV-vis 
measurements. e Obtained by simultaneous analysis of UV-vis and potentiometric data. f Combined pH-potentiometric and 
UV-vis competition methods by using bimp
5−
 (edta
4−
 in the case of [Cu(dompa)]
+
). g Taken from ref. 17; a log K
H
6 value was 
also reported for dota
4−
. h Taken from ref. 18. i Taken from ref. 8. 
 
The thermodynamic stability of the Mn
2+
 complexes of dodpa
2−
 and Medodpa
2−
 were obtained using 
potentiometric pH titrations with 1 : 1 Mn
2+
: ligand ratios. During the titrations a brown precipitate 
(presumably MnO(OH)2) was formed at high pH values (pH = 11–12), and therefore this pH range was not 
used for stability constant determination. The titration curves (Fig. S1 and S2, ESI†) could be fitted assuming 
the formation of both protonated ([MnH(L)]
+
) and di-protonated ([MnH2(L)]
2+
) complex species. However, 
good agreement between the species distribution curve obtained by pH-potentiometry and the 
1
H-
relaxometric profile obtained as a function of pH could only be achieved when only monoprotonated species 
were considered (Fig. S3, ESI†). The stability constants determined for the dodpa2− and 
 
 
Medodpa
2−
 complexes are very similar, indicating that the presence of methyl groups in the latter does not 
introduce significant steric hindrance for the coordination of the ligand to the metal ion (Table 1). The 
species distribution diagrams (Fig. S4, ESI†) indicate that the dissociation of the complexes starts below 
pH∼5.0, and consequently the formation of the protonated form [MnH(L)]+ (L = dodpa2− or Medodpa2−) is 
observed in the pH range of 3.0–5.0. 
Stability constant determination was also performed using 
1
H relaxometry, as the determination of stability 
constants using independent methods provides more reliable results. The relaxivities of [Mn(dodpa)] and 
[Mn(Medodpa)] at neutral pH (25 °C, 20 MHz) are 1.02 and 1.04 mM
−1
 s
−1
, respectively. These values are 
close to those observed for Mn
2+
 complexes that lack inner-sphere water molecules such as [Mn(do3a)]
−
.
21
 
The relaxivity of both complexes steadily increases below pH ∼ 5, reaching a value of 8.16 mM−1 s−1 at pH < 
3. This relaxivity value corresponds to that of [Mn(H2O)6]
2+
,
22
 which confirms that the increase in proton 
relaxivity observed below pH 5 is due to the dissociation of the complex. The stability constants obtained 
from potentiometric and relaxometric pH titrations are in excellent agreement (Table 1), although it must be 
stressed out that the stability constant of the protonated complex could not be determined reliably using the 
relaxometric method. This can be explained in terms of small differences in the relaxivities of the 
[Mn(dodpa)] and [Mn(Hdodpa)]
+
 complexes, as well as the relatively low abundance of the protonated 
species (max. ∼35% at pH = 3.80; Fig. S3, ESI†). 
 
 
Fig. 1. View of the structure of the [H4Medodpa]
2+
 cation present in crystals of Na[H4Medodpa](CF3COO)3·CF3COOH 
(hydrogen-bonding data: N(3)⋯N(1), 3.100(3) Å, N(3)–H(3)⋯N(1), 2.42 Å, N(3)–H(3)⋯N(1), 144.7°; N(5)⋯N(6), 
3.050(3) Å, N(5)–H(5)⋯N(6), 2.31 Å, N(5)–H(5)⋯N(6), 139.8°). 
 
 
A comparison of the stability constants determined for the Mn
2+
 complexes of dodpa
2−
 and Medodpa
2−
 with 
those determined for the [Mn(dompa)]
+
 complex indicates that the attachment of a second picolinate moiety 
to the macrocyclic polyamine backbone results in a noticeable increase in the stability of their 
Mn
2+
 complexes. Indeed, the log KMnL values determined for the complexes of dodpa
2−
 and Medodpa
2−
 are 
ca. 3 log K units higher than those determined for [Mn(dompa)]
+
. This is confirmed by the calculation of 
pMn values, defined as pMn = −log[Mn]free, for pH = 7.4, cL = 10 μM and cMn
2+
 = 1 μM.23Indeed, the 
protonation constants and stability constants listed in Table 1 provide the following pMn values: 11.81 
(dodpa
2−
), 12.92 (Medodpa
2−
) and 9.07 (dompa
−
).
18
 These results suggest that the second picolinate unit of 
dodpa
2−
 and Medodpa
2−
 is involved in coordination to the Mn
2+
 ion, thereby contributing to the enhancement 
of the stability of these complexes. 
The Cu
2+
 complexes of dodpa
2−
 and Medodpa
2−
 were titrated using pH-potentiometry. However, the fitting of 
the titration curves indicated that the complexes (monoprotonated and diprotonated complexes) were formed 
quantitatively already at acidic pH (pH ∼ 1.8). Thus, only protonation equilibria of the complexes in the pH 
range 1.8–11.8 could be determined from these data. However, it became clear that either a direct 
spectrophotometric measurement with the use of the d–d absorption band of the complexes or a competition 
titration with an appropriate open-chain ligand (e.g. edta
4−
) followed by UV-vis spectrophotometry, 
combined with pH-potentiometry, must be used to determine the stability of these complexes.
18
 At first, out-
of-cell samples were prepared and equilibrated in strongly acidic media for a week (H
+
 ion concentration was 
in the range of 15.91–714.8 mM for the dodpa2− and 15.86–631.5 mM for the Medodpa2− systems). 
Subsequently, the visible absorption spectra were acquired (Fig. 2, S6 and S7, ESI†), and the molar 
absorption coefficients of the [Cu(L)] and [Cu(HL)] complexes of dodpa
2−
 and Medodpa
2−
 were determined 
at 11 wavelengths near the absorption maxima (550–800 nm). A simultaneous fitting of pH-potentiometric 
and UV-vis titration data acquired in the pH range of 1.85–8.26 was performed (at two different total 
concentrations), which provided the equilibrium constants characterizing the Cu
2+
: dodpa
2−
: H
+
 system. 
Unfortunately, in the case of the Medodpa
2−
 system some precipitation occurred in the samples with high 
acid concentrations. Therefore, a ligand-competition method was applied for stability constant determination 
in which the Cu
2+
: dodpa
2−
-H
+
 system was used as a test system, since in this case it was possible to 
determine reliable stability constants by direct methods. The bimp
5−
 ligand (H5bimp = 
bis(iminodicarboxymethyl-N-methyl)phosphinic acid; Fig. S5, ESI†) was selected as a competing chelator, 
as the stabilities of its Cu
2+
 complexes were determined by multiple methods [log K[Cu(bimp)]
2−
 = 19.3 by pH-
potentiometry (I = 1.0 M Me4NCl) and log K[Cu(bimp)]
2−
 = 17.5 and log K[Cu2(bimp)2]
4−
 = 40.0 for the dimer by 
2D EPR spectroscopy (I = 0.10 M NaCl)].
24
 The corresponding log K[Cu(bimp)]
2−
 value obtained in the current 
study by using a combined pH-potentiometric and UV-vis spectrophotometric approach equals 18.34(3) (I = 
0.15 M NaCl), which is in acceptable agreement with the previously reported data. Using the protonation 
constants of dodpa
2−
 and bimp
5−
 ligands and the stability constants of the Cu
2+
 complexes formed with these 
ligands, a speciation distribution curve was calculated in order to estimate the pH range where the 
competition titration can be carried out (Fig. 3). 
The curves shown in Fig. 3 indicate that the competition reaction may be carried out either in the pH range of 
3.6–4.0 where competition occurs between [Cu(Hdodpa)]+ and [Cu(bimp)]3− complexes or above pH = 7.0, 
where the exchange between [Cu(dodpa)] and [Cu(bimp)]
3−
 complexes may serve as a tool for stability 
constant determination. Both pH ranges were tested, but at high pH the Cu
2+
 exchange between the ligands 
was found to occur slowly at room temperature. Therefore, samples containing 1.99 mM Cu
2+
 and 2.042 mM 
dodpa
2−
 with increasing amounts of the bimp
5−
 ligand (concentration range 2.052–50.05 mM) in the pH 
range 3.76–4.10 were prepared, equilibrated for 24 hours and their spectra were recorded (Fig. S8, ESI†). 
Being in possession of the molar absorption coefficients of absorbing species present in the equilibrium, the 
stability constants of the [Cu(Hdodpa)]
+
 and [Cu(dodpa)] complexes were determined (Table 1; the fitting 
parameter was 0.0040 absorbance units for the 164 data points fitted). As can be seen from the data listed 
in Table 1, excellent agreement was found for the cumulative constant characterizing the formation of the 
 
 
[Cu(Hdodpa)]
+
 complex determined by other techniques and using the above described competition method. 
The stability constant of the [Cu(dodpa)] complex turned out to deviate slightly from that determined by the 
simultaneous fitting of the pH-potentiometric and UV-vis spectroscopic data, which is not very surprising 
since the fraction of the given complex present in the equilibrium in the pH range used for the studies 
remains always below 20%. However, using the equilibrium constant determined for [Cu(Hdodpa)]
+
 = 
[Cu(dodpa)] + H
+
 from independent studies (pH-potentiometric and UV-vis methods) it is possible to 
calculate log K[Cu(dodpa)]. Applying the same method to the Cu
2+
: Medodpa
2−
: H
+
 system for the samples 
containing 1.99 mM Cu
2+
 and 2.019 mM Medodpa
2−
 with increasing amounts of the bimp
5−
 ligand 
(concentration range 2.002–80.28 mM, pH range 3.63–4.30, Fig. S9, ESI†) allowed us to estimate the 
cumulative constant characterizing the formation of the [Cu(HMedodpa)]
+
 complex (Table 1). As for 
[Cu(dodpa)], the stability constant of [Cu(Medodpa)] was calculated with the use of its deprotonation 
constant. 
 
 
Fig. 2. Absorption spectra of the Cu
2+–dodpa2− system as a function of −log cH
+
 recorded in the range  
of −log cH
+
 = 1.81–8.15 (I= 0.15 M NaCl; [Cu2+] = [dodpa] = 1.654 mM, l = 1 cm, 25 °C). 
 
 
 
 
 
 
Fig. 3. Species distribution diagram for the Cu
2+
:dodpa : bimp system  
(1 : 1 : 1) ([Cu
2+
] = [dodpa] = [bimp] = 2 × 10
−3
 M). 
 
Owing to the slow rates of complexation often observed for reactions of Ln
3+
 ions and macrocyclic ligands, 
stability constant determination was attempted by equilibrating solutions containing stoichiometric amounts 
of the Ln
3+
 ion (Gd
3+
 or Ce
3+
) and the ligand (dodpa
2−
 or Medodpa
2−
) at pH values for which complexation is 
expected to take place (pH = 5.45). The rate of complex formation was assessed by following the changes in 
the UV-Vis absorption spectrum (Ce
3+
) or relaxivity (Gd
3+
) of the solution during the course of several 
months (Fig. S10, ESI†). These preliminary studies showed that the thermodynamic equilibrium was not 
reached even after six months. To circumvent this problem, the stability of the Gd
3+
 complexes was assessed 
by provoking the partial dissociation of the complexes upon decreasing the pH. For that purpose, the 
[Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 complexes were prepared using strong heating at high pH values (8.6 and 
9.8, respectively, see the Experimental section for full details) by gradual NaOH additions. Batch solutions 
of the complexes (1 mM) covering the pH range 2.5–8.0 with the use of a buffer cocktail consisting of 
piperazine (pip), N-methyl-piperazine (nmp) and N,N′-dimethyl-piperazine (dmp) were prepared, and the 
dissociation of the complexes was followed using the relaxometric method. Solutions of the complexes at 
three representative pH values were taken (3.00, 4.94 and 7.05) to assess the time required to reach 
thermodynamic equilibrium. The relaxivity of these solutions was followed over time, reaching the steady 
state after four months. 
The relaxivity of equilibrated solutions of [Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 at different pH values was used 
to estimate the stability constants of these complexes. The relaxivity data show that complexation occurs in 
the pH range 2.5–5.0 (Fig. 4). The relaxivities of [Gd(dodpa)]+ and [Gd(Medodpa)]+ recorded above pH 5.5 
(25 °C, 20 MHz) amount to 3.28 and 2.01 mM
−1
 s
−1
, respectively. These values are in agreement with those 
reported previously,
15
 while below pH 5.5 the relaxivity increases due to the dissociation of the complex. At 
pH 3.0 the observed relaxivity values correspond well to the value reported for [Gd(H2O)8]
3+
.
25
 The 
thermodynamic stabilities of [Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 (log K[Gd(dodpa)]
+
 = 17.27(16) and log
K[Gd(Medodpa)]
+
 = 17.59(12)) are clearly lower than those of the complexes with dota
4−
 and do3a
3−
, and one 
order of magnitude lower than those reported for the related ligand bp12c4
2−
. 
 
 
 
 
Fig. 4. Relaxivity pH profiles of the equilibrated [Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 complexes ([Gd(L)]
+
 = 1.0 × 
10
−3
 M in a buffer cocktail consisting of 25–25–25 mM of pip, nmp and dmp, t = 25 °C, I = 0.15 M NaCl, B = 0.47 T). 
 
Acid catalysed dissociation of the Gd
3+
 complexes and metal exchange reactions of the Mn
2+
 complexes 
The dissociation of Gd
3+
 and other metal complexes in vivo may proceed by different pathways:
26
 (1) 
spontaneous dissociation, characterized by a rate constant k0; (2) proton assisted dissociation characterized 
by the protonation constants KGdHL and KGdH2Land rate constants kGdHL and k
H
GdHL (often denoted 
as k1 and k2); (3) ligand-assisted dissociation characterized by the stability constant of mixed ligand 
complexes KLGdL* and rate constant kLGdL*; (4) metal-ion-catalysed dissociation characterized by the stability 
constant of the dinuclear complexes KGdLM (where M = Zn, Cu or Eu) and rate constant kGdLM (often 
expressed as k
M
3). The dissociation of complexes with macrocyclic ligands such as dota
4−
 often occurs very 
slowly due to their compact and highly rigid structure, which results in high kinetic inertness towards 
complex dissociation. As a consequence, the acid catalysed process constitutes the main dissociation 
pathway for the complexes of this class, with the ligand assisted and metal-ion-catalysed pathways being 
negligible.
4,17
 
The acid-catalysed dissociation rates of [Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 complexes have been studied 
using the relaxometric method. In the case of [Gd(dodpa)]
+
, acid solutions with HCl concentrations in the 
range 0.01–0.25 M were used. However, the [Gd(Medodpa)]+ complexes were found to be significantly more 
inert, and therefore higher acid concentrations had to be employed (0.01–0.8 M). Under these conditions the 
complexes are thermodynamically unstable and dissociate completely. The rates of dissociation can be 
expressed by eqn (5): 
 
  −
d[ML]𝑡
d𝑡
= 𝑘obs[ML]𝑡      (5) 
 
 
 
Plots of the obtained kobs values vs. H
+
 concentration for the different complexes are shown in Fig. 5. These 
plots are characteristic of a quadratic dependence on proton concentration, which indicates that the 
dissociation might take place by both the proton-independent (characterized by k0) and the proton-assisted 
pathways with the formation and dissociation of mono- and diprotonated complexes (characterized 
by k1 and k2, respectively). Similar quadratic dependencies were observed for the acid catalysed dissociation 
of [Ce(dota)]
−
,
27
 [Eu(do3a-pic)]
−
 (ref. 11) and [Ce(bp12c4)]
+
.
8
 For other complexes with macrocyclic ligands 
such as [Eu(dota)]
−
 and [Ln(pcta)] these plots show a saturation behaviour, which indicates that the 
complexes dissociate following the formation of a protonated complex species.
4,28
 Thus, the observed first 
order dissociation rate constants were fitted to eqn (6): 
 
  𝑘obs =
𝑘0+𝑘H𝐾[M(HL)][H
+]+𝑘H
H𝐾[M(HL)]𝐾[M(H2L)][H
+]2
1+𝐾[M(HL)][H
+]+𝐾[M(HL)]𝐾[M(H2L)][H
+]2
  (6) 
 
Fits of the experimental data according to eqn (6) showed that for both complexes, 1 ≫ K[Gd(HL)][H
+
] 
+ K[Gd(HL)]K[Gd(H2L)] [H
+
]
2
. Thus, eqn (6) can be simplified to give: 
 
  𝑘obs = 𝑘0 + 𝑘1[H
+] + 𝑘2[H
+]2    (7)  
 
where k0 is the rate constant characterizing the spontaneous dissociation process and k1 and k2 the rate 
constants associated with the proton assisted pathway. The results obtained from the fittings are summarized 
in Table 2. The dissociation of [Gd(dodpa)]
+
 is characterized by a k1 constant that is one order of magnitude 
lower than that of the do3a
3−
 complex, which shows that the [Gd(dodpa)]
+
 complex is remarkably inert. 
The k1 value determined for [Gd(Medodpa)]
+
 is even smaller, which indicates that the introduction of the 
methyl groups into positions 1 and 7 of the cyclen unit results in a significant decrease of the rate constants 
characterizing the proton-assisted dissociation pathway. The k1 values determined for [Gd(dodpa)]
+
 and 
[Gd(Medodpa)]
+
 fall between those reported for the complexes of do3a
3−
 and dota
4−
. The analysis of the 
kinetic data for [Gd(Medodpa)]
+
 indicates that spontaneous dissociation also contributes to the overall 
decomplexation process, most likely due to the slower proton assisted mechanism. Due to the different 
mechanisms operating for these systems, their kinetic inertness was assessed by calculating their kobs values 
with [H
+
] = 0.1 M. From these values the half-life of each complex under these conditions was obtained 
as t1/2 = ln 2/kobs. The t1/2 values indicate the following sequence of kinetic inertness for this family of 
Gd
3+
 complexes: do3a
3−
 < dodpa
2−
 < Medodpa
2−
 < dota
4−
. The higher kinetic inertness of [Gd(Medodpa)]
+
 
compared to [Gd(dodpa)]
+
 is probably related to the more compact structure of the former, which is 
associated with the steric hindrance caused by the methyl groups and results in the absence of coordinated 
water molecule.
15
 Interestingly, both [Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 are considerably more inert than the 
related complex [Gd(bp12c4)]
+
, for which kobs can be estimated to be 0.1 s
−1
 at [H]
+
 = 0.1 M in the absence 
of exchanging metal ions, yielding a half-life of 6.9 s under these conditions. Furthermore, the dissociation 
rates of [Gd(bp12c4)]
+
 were found to increase significantly by the presence of metal ions such as Zn
2+
 and 
Cu
2+
, while the dissociation of [Gd(Medodpa)]
+
 and [Gd(dodpa)]
+
 is not affected by these metal ions.
8
 These 
results imply that the substitution of the 1,7-diaza-12-crown-4 moiety of bp12c4
2−
 by a cyclen unit has a 
relatively small impact on the thermodynamic stability of the Gd
3+
 complexes (see above), while it has a 
beneficial effect on their kinetic inertness. 
 
 
 
Fig. 5. Pseudo-first-order rate constants measured for the acid-assisted dissociation of [Gd(dodpa)]
+
 and 
[Gd(Medodpa)]
+
complexes, kobs, as a function of proton concentration. The solid lines correspond 
to the fits of the data as described in the text. 
 
Mn
2+
 complexes are known to form kinetically less inert complexes than the Ln
3+
 ions, and thus their 
inertness can be easily accessed by following the transmetallation reactions occurring between the 
Mn
2+
 complexes and a suitable exchanging metal ion. The Cu
2+
 ion is usually selected for such a purpose as 
it allows using UV-vis spectrophotometry to gain the kinetic data. The metal exchange reactions of the 
[Mn(dodpa)] and [Mn(Medodpa)] complexes were studied in the presence of a high excess (10–40 fold) of 
the exchanging metal ion to ensure the pseudo-first-order conditions. Because the rates of the exchange 
reactions were found to be independent of the metal ion concentration, the direct involvement of the metal 
ion in the exchange process can be ruled out (in the pH range studied). This is somewhat surprising 
considering that the ligands offer eight potential donor atoms, while the coordination numbers observed more 
often in the literature for the Mn
2+
 ion are 6 and 7. However, this is consistent with the thermodynamic 
stability constants, which suggest the coordination of both picolinate pendant arms to the Mn
2+
 ion in the 
complexes, as for the complexes with uncoordinated donor atoms (e.g. dota
4−
) the presence of an exchanging 
metal ion usually affects the dissociation rates.
31
 
The rate constants kobs plotted as a function of pH (Fig. 6) indicate a saturation like behaviour that turns into 
a nearly straight line for [Mn(dodpa)] at high cH
+
 concentration. The pseudo-first order rate constants 
determined were fitted to eqn (7) to give the rate constants presented in Table 3. The kinetic data indicate 
that the Mn
2+
 complexes of these dipicolinate ligands dissociate via the spontaneous and acid catalysed 
dissociation pathway, characterized by the k0 and k1 rate constants, respectively. In spite of the fact that the 
rate constants were evaluated using a wide pH range by including pH values up to pH = 4, the rate constants 
of spontaneous dissociation could not be determined with high accuracy (as the values determined were 
comparable to their uncertainties k0 = (2.2 ± 2.9) × 10
−5
 s
−1
 for [Mn(dodpa)] and k0 = (1.9 ± 1.7) × 10
−5
 s
−1
 for 
[Mn(Medodpa)]), so that the values reported here can be taken as the upper limits for these rate constants. 
Nevertheless, we decided to use them in the calculation of half-lives of the complexes, as near physiological 
conditions spontaneous dissociation represents the most important dissociation pathway. Besides this, for the 
[Mn(dodpa)] complex it was not possible to determine the second protonation constant (K[M(H2L)]) and the 
rate constant characterizing its dissociation through the diprotonated intermediate (k
H
H) independently, and 
 
 
thus only their product (k2 M
−2
 s
−1
) was calculated and included in Table 3. This intermediate was not 
observed for the [Mn(Medodpa)] complex, which was found to be less inert than the complex of the 
unsubstituted dodpa
2−
ligand, in contrast with the behaviour of the corresponding Gd
3+
 complexes. These 
results suggest that the steric hindrance brought by the methyl substituents affects negatively the kinetic 
inertness of the complexes formed with small metal ions such as Mn
2+
. 
 
Table 2. Proton dissociation rate constants of [Gd(dodpa)]
+
 and [Gd(Medodpa)]
+
 complexes and dissociation rates and 
half-lives calculated for [H]
+
 = 0.1 M. Data for related systems are provided for comparison. 
 
  dodpa
2−
 Medodpa
2−
 do3a
3− a,b
 dota
4− a,c
 
k 0/s
−1
  3.8(9) × 10
−6
  6.7 × 10
−11
 
k 1/M
−1
 s
−1
 2.5(4) × 10
−3
 8.3(4) × 10
−4
 2.3 × 10
−2
 1.8 × 10
−6
 
k 2/M
−2
 s
−1
 8.2(7) × 10
−2
 2.6(9) × 10
−4
   
k obs/s
−1
 at [H
+
] = 0.1 M 1.08 × 10
−3
 8.94 × 10
−5
 2.3 × 10
−3
 1.8 × 10
−7
 
t 1/2/s 641 7751 301 3.85 × 10
6
 
 
a From ref. 17. b Similar data were published by K. Kumar et al., ref. 29. c Similar values were reported by 
Desreux et al., ref. 30. 
 
 
 
Fig. 6. Pseudo-first-order rate constants measured for the acid-assisted dissociation of [Mn(dodpa)] and [Mn(Medodpa)] 
complexes, kobs, as a function of proton concentration. The solid lines represent the fits of the data to eqn (7). 
 
 
 
 
 
 
Table 3. Equilibrium constants, rate constants and half-lives of the reactions characterising the dissociation of 
Mn
2+
 complexes (25 °C, I = 0.15 M NaCl, 0.1 M chloroacetic acid and 0.05 M dmp buffer). 
 
 k 0/s
−1
 k 1/M
−1
s
−1
 k 2/M
−2
s
−1
 k 3/M
−1
s
−1
 Log K
H
1 K M
e
 t 1/2
e
(h) 
dodpa
2−
 (2.2 ± 2.9) × 10
−5
 0.46
b
 0.61 ± 0.24  3.45(4)  8.90 
Medodpa
2−
 (1.9 ± 1.7) × 10
−5
 97
c
   3.01(1)  8.38 
dompa
− a
 1.2 × 10
−3
 235   4.02  0.160 
dota
4− d
 1.8 × 10
−7
 4.0 × 10
−2
 1.6 × 10
3
 1.5 × 10
−5
 4.26 68 1037 
 
a Taken from ref. 18. b The value represents the product of kH × K[M(HL)] where kH = (3.8 ± 0.2) × 0
−3
 s
−1
 and K[M(HL)] = 
119 ± 13. c The value represents the product of kH × K[M(HL)] where kH = (1.8 ± 0.1) s
−1
 and K[M(HL)] = 53 ± 15. d Taken 
from ref. 31. e pH = 7.4; the concentration of the Zn
2+
exchanging metal ion used in the calculations was 1 × 10
−5
 M. 
 
Self-aggregation of [La(dodpa)]
+
 
Slow evaporation of aqueous solutions of [La(dodpa)]
+
 provided single crystals for X-ray diffraction 
measurements. Unfortunately, the poor quality of the crystals did not allow obtaining accurate structural 
data. However, the crystallographic data pointed to the presence of [La3(dodpa)3(H2O)3]
3+
 trinuclear entities 
in the solid state formed by the presence of bridging carboxylate units. In a recent study we demonstrated 
that binucleating do3a
3−
 ligands containing different spacers undergo self-aggregation into nanoparticles, 
which was attributed to the presence of bridging carboxylate units.
32
 In the light of these results, we decided 
to investigate whether the [La(dodpa)]
+
 complex experiences self-aggregation in aqueous solutions. Thus, we 
have performed DOSY (diffusion-ordered NMR spectroscopy) experiments on D2O solutions of the 
diamagnetic [La(dodpa)]
+
 and [Lu(dodpa)]
+
 complexes. Taking the diffusion coefficient of HDO as a 
reference (D = 1.92 × 10
−10
 m
2
 s
−1
 at 298 K),
33
 these experiments (Fig. 7) provided diffusion coefficients D at 
298 K amounting to 2.51 × 10
−10
 and 3.78 × 10
−10
 m
2
 s
−1
 for the La
3+
 and Lu
3+
 complexes, respectively. 
These data imply that the Lu
3+
 complex diffuses faster in solution than the La
3+
 complex, in line with the 
formation of aggregates in the latter case. These self-diffusion coefficients depend on the solution 
viscosity η, the van der Waals radius of the complex a, and a translational microviscosity factor fS
t
 that 
accounts for the discrete nature of the solution through the Stokes–Einstein for translation (eqn (8)):34 
 
     𝐷 =
𝑘B𝑇
6𝜋𝑎𝜂
     (8) 
 
This equation gives van der Waals radii of 4.69 and 7.07 Å for the Lu
3+
 and La
3+
 complexes at 298 K using 
the diffusion coefficients obtained from DOSY experiments and η(D2O) = 1.232 × 10
−3
 Pa s.
35
 DFT 
calculations performed on the [Lu(dodpa)]
+
complex using the TPSSh functional allowed us to estimate the 
volume of this complex, defined as the volume inside a contour of 0.001 electron Bohr
−3
. We obtained a 
molecular volume of 501.89 Å
3
, which is very similar to that reported for mononuclear complexes with a 
similar size.
36
 The radius of the complex was then evaluated to be a = 4.93 Å by considering a sphere having 
the same volume. This value is in very good agreement with that obtained from DOSY measurements, 
indicating that the [Lu(dodpa)]
+
 complex is present as a mononuclear species in solution. 
The crystallographic data obtained for [La(dodpa)]
+
 were used as an input geometry for structure 
optimization of [La3(dodpa)3(H2O)3]
3+
. Due to the large size of this system, geometry optimizations were 
performed at the HF level (see the computational details below). Subsequent single point energy calculations 
using the TPSSh functional gave a molecular volume of 1663.77 Å
3
, which corresponds to a sphere with a 
 
 
radius of 7.35 Å. This value is in excellent agreement with that obtained from DOSY experiments (7.07 Å), 
which confirms that the La
3+
 complex of dodpa
2−
 forms stable trinuclear aggregates in aqueous solution. The 
optimized geometry of [La3(dodpa)3(H2O)3]
3+
 (Fig. 8) shows that the trinuclear entity is stabilized by 
bridging bidentate carboxylate groups (μ1,3-carboxylate).
37
 Hydrogen-bonding interactions involving the 
ligand NH groups and oxygen atoms of carboxylate groups of neighbouring [La(dodpa)(H2O)]
+
 units appear 
to provide additional stabilization to the trinuclear edifice. The four five-membered chelate rings formed 
upon coordination of the cyclen moiety adopt mixed (δλδλ) conformations.38 
 
 
Fig. 7. Superposed 
1
H DOSY (D2O, 500 MHz, 298 K, pD ∼ 7.0) experiments of [Lu(dodpa)]
+
 (red) and 
[La3(dodpa)3(H2O)3]
3+
(blue). 
 
Further support for the formation of trinuclear edifices was provided by the 
1
H NMR spectra and ESI-MS. 
Indeed, while the 
1
H spectrum recorded for the [Lu(dodpa)]
+
 complex is in agreement with an effective 
C2 symmetry of the complex in solution, the spectrum of the La
3+
 analogue points to a C1 symmetry (Fig. 7, 
see also Fig. S11, ESI†). The 1H spectrum of the La3+ complex shows six signals due to proton nuclei of the 
pyridyl units, which indicates that the two picolinate pendant arms are magnetically non-equivalent. One of 
these signals is observed at a particularly high field (6.27 ppm). Inspection of the structure of the trimer 
obtained with HF calculations shows that a proton of one of the picolinate pendant arms is directed toward 
the aromatic ring current of a picolinate group of a neighbouring pendant arm (CH⋯C distances = 3.2–3.6 
Å). The large low-frequency shift of the resonance due to this proton is therefore attributable to a ring current 
shift effect provoked by the neighbouring pyridyl unit, which results in a shielding for any nuclei above or 
below that ring. The ESI
+
-MS of [La(dodpa)]
+
 presents a peak at m/z 886.16 corresponding to the trinuclear 
entity [(La(dodpa))3Cl]
2+
, together with a peak at m/z 1193.21 due to [(La(dodpa))2Cl]
+
 and the peak due to 
the mononuclear complex [La(dodpa)]
+
 at m/z 579.12 (Fig. S12, ESI†). The presence of peaks in the MS due 
to the monomeric (100%), trimeric (60%) and dimeric (2%) entities indicates dissociation of the aggregates 
under the mild conditions of the electrospray ionization, pointing to a relatively low stability of the trimer. 
 
 
 
Fig. 8. Optimized geometry of [La3(dodpa)3(H2O)3]
3+
 obtained with HF calculations. Hydrogen atoms attached to 
carbon atoms are omitted for simplicity. 
 
X-ray structure of [Cu(dodpa)]·5H2O 
Single crystals of formula [Cu(Medodpa)]·5H2O were obtained by slow evaporation of a concentrated 
aqueous solution of the complex, prepared by refluxing a 1 : 1 mixture of the ligand and copper(II) 
perchlorate at neutral pH (pH was adjusted by addition of K2CO3). Crystals contain the neutral complex 
[Cu(dodpa)] and water molecules establishing a hydrogen-bonding network with oxygen atoms of the 
carboxylate groups. A view of the structure of the complex is shown in Fig. 9, which also provides bond 
distances of the metal coordination environment. The metal ion is six-coordinated, being directly bound to 
four nitrogen donor atoms of the cyclen unit and the two donor atoms of one of the picolinate pendant arms. 
The second picolinate group remains uncoordinated. The distance from the metal ion and N1 is considerably 
longer than the remaining bond distances of the metal coordination environment [Cu1–N1 = 2.423(4) Å], 
which shows that this donor atom is weakly bound to the metal ion. A similar situation was previously 
observed for the [Cu(dompa)]
+
 complex.
38
  
Surprisingly, the cyclen unit adopts a conformation in which the five-membered chelate ring formed upon 
coordination of the ethylenediamine moieties of the ligand adopt a mixed conformation (λδλδ) instead of the 
(δδδδ) [or (λλλλ)] conformations often observed in the solid state for metal complexes with cyclen-based 
ligands (i.e. [Cu(dompa)]
+
).
39
 The coordination polyhedron can be best described as a distorted octahedron, 
with the trans angles O1–Cu1–N1 (151.57(11)°) and N4–Cu1–N2 (148.80(16)°) deviating considerably from 
the value expected for a regular octahedron (180°), and the cis angles falling within the range 74.7–116.2°. 
 
 
 
 
Fig. 9. View of the X-ray structure of the [Cu(Medodpa)] complex. The ORTEP plot is at the 30% probability level. 
Hydrogen atoms and water molecules are omitted for simplicity. Bond distances: Cu1–N1 2.423(4), Cu1–N2 2.135(5), 
Cu1–N3 2.062(5), Cu1–N4 2.102(5), Cu1–N5 2.045(4), Cu1–O1 2.201(4) Å. 
 
Conclusions 
We have herein reported the results of the equilibrium, dissociation kinetics, DFT and X-ray crystallographic 
studies performed for two cyclen derivatives featuring two picolinate moieties in trans positions to each 
other (1,7-disubstituted tetraazacyclododecane). The protonation constants of the ligands and thermodynamic 
stability constants of the complexes of dodpa
2−
 and Medodpa
2−
 formed with Mn
2+
, Cu
2+
 and Gd
3+
 have been 
determined by a simultaneous fit of the data obtained by multiple methods (pH potentiometry, UV-vis 
spectrophotometry and 
1
H-relaxometry). The stability constants of the complexes formed with dodpa
2−
 and 
Medodpa
2−
 do not differ significantly (e.g. log K[Mn(dodpa)] = 17.40 vs. log K[Mn(Medodpa)] = 17.46, log K[Cu(dodpa)] 
= 24.34–25.17 vs. log K[Cu(Medodpa)] = 24.74 and log K[Gd(dodpa)]
+
 = 17.27 vs. log K[Gd(Medodpa)]
+
 = 17.59), which 
indicates that the steric hindrance brought by the methyl groups has no significant effect on the stability of 
the complexes. Besides, the results reported indicate that these ligands form complexes with thermodynamic 
stability quite similar to that of the 1,7-dioxa-4,10-diazacyclododecane based bp12c4
2−
 chelator reported 
some years ago (the stability constants are about an order of magnitude lower than the value reported for 
[Gd(bp12c4)]
+
 in the literature). At the same time the kinetic inertness of the Gd
3+
 complexes of dodpa
2−
 and 
Medodpa
2−
 is considerably higher than that of the [Gd(bp12c4)]
+
 as evidenced by the noticeable decrease in 
the rate constant characterizing the acid catalyzed dissociation. This is very likely the consequence of the 
somewhat more compact and more rigid structure of the complexes of dodpa
2−
 and Medodpa
2−
 in comparison 
with the Gd
3+
 complex formed with the bp12c4
2−
 chelator. The considerable increase in the stability 
constants (ca. 3 log K units) and inertness of the [Mn(dodpa)] and [Mn(Medodpa)] complexes (characterized 
 
 
by the calculated half-lives of the dissociation at pH = 7.4) vs. the corresponding data published for the 
cyclen monopicolinate derivative ([Mn(dompa)]
+
) suggest that both picolinate moieties are involved in the 
coordination of Mn
2+
 in the dipicolinate derivatives. However, the stability of the Cu
2+
 complexes as well as 
the X-ray structure of the [Cu(Medodpa)] complex indicate that the ligand binds the Cu
2+
 ion in a 
hexadentate fashion, one of the picolinate arms remaining uncoordinated. The greater size of the lighter 
Ln
3+
 ions (e.g. La
3+
), and the fact that the carboxylate moiety may bind the metal ions in a bridging mode, 
results in the formation of trinuclear complexes in solution. The existence of these species for the lighter and 
their absence for the heavier lanthanide ions was proved on diamagnetic [La(dodpa)]
+
 and [Lu(dodpa)]
+
 by 
means of NMR spectroscopy (DOSY) and DFT calculations. 
 
Experimental and computational methods 
General 
ESI-TOF mass spectra were recorded using an LC-Q-q-TOF Applied Biosystems QSTAR Elite spectrometer 
in the positive ion mode. 
1
H and 
13
C NMR spectra were recorded on a Bruker Avance 500 spectrometer 
equipped with a dual cryoprobe or on a Bruker Avance 300 spectrometer. Chemical shifts are reported 
in δ values. The MnCl2, CuCl2 and GdCl3 stock solutions were prepared from the chemicals of highest 
analytical grade using bidistilled water. The concentrations of the stock solutions were determined by 
complexometric titration with standardized Na2H2edta and eriochrome black T indicator in the presence of 
ascorbic acid and potassium hydrogen tartrate at pH = 10.0 (NH4Cl/NH3·H2O buffer) for MnCl2, murexide 
indicator at pH = 5.0 (urotropin buffer) for CuCl2 and xylenol orange indicator at pH = 5.8 (urotropin buffer) 
for the GdCl3 stock solution. 
pH-Potentiometry 
The protonation constants of the ligands (dodpa
2−
, Medodpa
2−
 and do3a
3−
 for comparative purposes) and the 
equilibrium involving the Mn
2+
 and Cu
2+
 metal ions were studied by pH-potentiometry. The pH-
potentiometric titrations were carried out with a Metrohm 785 DMP Titrino titration workstation with the use 
of a Metrohm 6.0233.100 combined electrode in the pH range of 1.8–11.8. For the calibration of the pH-
meter, KH-phthalate (pH = 4.005) and borax (pH = 9.177) buffers were used, while the liquid junction 
potential was corrected by applying the method proposed by Irving et al.
40
 A 0.15 M NaCl ionic strength was 
set in the samples and a CO2-free NaOH stock solution (standardized by KH-phthalate titration) kept under a 
nitrogen protecting atmosphere was used as the titrant (c = 0.1914 M). The titrated samples (starting volume 
of 6 mL) were stirred mechanically and thermostated at 25.0 ± 0.1 °C using a circulating water bath. To 
avoid the effect of CO2, N2 gas was bubbled through them during the titration process. The protonation 
constants of the ligands were determined from the titration data obtained by titrating 1.94 and 2.73 mM 
(dodpa
2−
), 2.56 and 2.86 mM (Medodpa
2−
) and 1.86 mM (do3a
3−
) ligand solutions with the base. The total 
number of fitted data was 384, 419 and 181 data pairs with fitting parameters (ΔV, defined as the difference 
between the experimental and calculated titration curves expressed in cm
3
 of the titrant or as the difference 
between the experimental and calculated absorbances) of 2.93 × 10
−3
, 3.27 × 10
−3
 and 5.86 × 10
−3
 cm
3
, 
respectively). The concentrations of the ligand stock solutions were also determined from these data by 
comparing the titration curves obtained in the presence and absence of a 2-fold excess of Mn
2+
. The stability 
constants of the Mn
2+
 complexes (two parallel titrations using 1.99, 2.94 mM and 2.54 mM solutions) 
solutions giving 376, 442 and 264 data pairs with fitting parameters ΔV = 3.79 × 10−3, 4.98 × 10−3 and 6.15 × 
10
−3
 cm
3
 for the dodpa
2−
, Medodpa
2−
 and do3a
3−
 ligands, respectively) and the protonation equilibria of the 
Cu
2+
complexes were also studied by direct pH-potentiometry (two parallel titrations using 1.98 and 2.04 mM 
solutions providing 244 and 690 data pairs with ΔV = 5.59 and 4.33 × 10−3 cm3), allowing five minutes for 
 
 
the sample equilibrium to be attained. For the calculation of the equilibrium constants the PSEQUAD 
program was used.
41
 
UV-vis spectrophotometry 
The stability constants of the Cu
2+
 complexes (using the so-called batch method), as well as the metal 
exchange reactions of the Mn
2+
 complexes using the Cu
2+
 ion as a ligand scavenger, were studied by UV-vis 
spectrophotometry. The spectrophotometric measurements were performed with the use of a Cary 1E 
spectrophotometer at 25 ± 0.1 °C, using semi-micro 1.0 cm cuvettes. The molar absorptivities of CuCl2 and 
the [Cu(dodpa)], [Cu(Hdodpa)]
+
, [Cu(Medodpa)] and [Cu(HMedodpa)]
+
 complexes were determined at 21 
wavelengths (550–750 nm range) by recording the spectra of 2.0 × 10−3, 4.0 × 10−3, 6.0 × 10−3 and 8.0 × 10−3 
M solutions. The molar absorptivities of the [Cu(H2dodpa)]
2+
 complex at the same wavelengths were 
determined by fitting the pH-potentiometric and UV-vis spectrophotometric data simultaneously when the 
molar absorptivity of the species present in the equilibrium was known (and fixed) from independent 
experiments. The stability of the Cu
2+
 complexes was also determined by competition titration with the use 
of the open chain ligand derivative bis(aminomethyl)phosphinic acid (bimp
5−
). The equilibrium in the Cu
2+
-
bimp
5−
-H
+
 system has been studied previously in the literature
24
 by multiple methods, but it was also 
determined in the current study from the simultaneous fit of the pH-potentiometric and UV-vis 
spectrophotometric (batch samples) titration results. The protonation and stability constants determined are 
as follows: log β[HL] = 9.36(1), log β[H2L] = 15.92(1), log β[H3L] = 18.69(2), log β[H4L] = 20.74(2), log β[H5L] 
= 22.23(5), log β[CuL] = 18.39(3) and log β[CuHL] = 21.19(2) with a fitting parameter of 4.99 × 10
−3
 cm
3
 for the 
219 data pairs fitted. The competition titrations were carried out in the pH ranges of 3.6–4.0 (dodpa2−) and 
3.6–4.3 (Medodpa2−) where the exchange reaction was found to occur within 24 hours. Samples containing 
1.99 mM Cu
2+
 and 2.042 mM dodpa
2−
 or 1.99 mM Cu
2+
 and 2.019 mM Medodpa
2−
 with increasing amounts 
of the bimp
5−
 ligand (in the concentration range 2.052–50.05 mM for dodpa2− and 2.002–80.28 mM for 
Medodpa
2−
) were prepared, equilibrated and visible spectra recorded. Being in possession of the molar 
absorption coefficients of all the absorbing species the cumulative constants characterizing the formation of 
the [Cu(HL)]
+
 (L = dodpa
2−
 and Medodpa
2−
 ligands) complexes were estimated. 
The decomplexation reactions of the Mn
2+
 complexes were carried out using the Cu
2+
 ion as the exchanging 
metal ion in the pH ranges 0.77 − 3.05 and 2.00 − 4.09 for the dodpa2− and Medodpa2− complexes, 
respectively. The concentration of the complexes was set to 2.5 × 10
−4
 M, while the exchange reactions were 
performed under pseudo-first order conditions where the metal ion was in a 20 fold excess (the direct 
involvement of the metal ion in the dissociation reaction was ruled out by studying the effect of 10–40 fold 
metal ion excess with the samples of relatively high pH) at 310 nm. The kinetic studies were carried out 
using chloroacetic acid (log K
H
1 = 2.85) and N,N′-dimethyl-piperazine (dmp, log K
2
H = 4.19) buffers at 0.10 
M and 0.05 M concentrations to maintain constant the pH in the samples. The pseudo-first-order rate 
constants (kobs) were calculated by fitting the absorbance–time data pairs to the following equation: 
 
  𝑋𝑡 = (𝑋0 − 𝑋e)e
−𝑘obs
        𝑡
+ 𝑋e     (9) 
 
where Xt, X0 and Xe are the absorbance (or relaxivity) at time t, at the start and at equilibrium, respectively. 
The calculations were performed with the computer program Micromath Scientist, version 2.0 (Salt Lake 
City, UT, USA), using a standard least-squares procedure. 
 
 
 
 
1
H-relaxometry 
The relaxivity, the stability constants of the Mn
2+
 and Gd
3+
 complexes and kinetic inertness of the 
Gd
3+
 complexes were studied using 
1
H-relaxometry. The longitudinal relaxation times (T1) of water protons 
were measured at 20 MHz with a Bruker Minispec MQ-20 NMR analyzer at 25.0 ± 0.2 °C (set and 
controlled with the use of a circulating water bath). T1 values were measured using the inversion recovery 
method (180°–τ–90°) by averaging 5–6 data points obtained at 14 different τ values (measurements on the 
equilibrated samples) while single T1 values obtained at 8 different τ values were collected and fitted as a 
function of time in the kinetic measurements. The relaxivities (mM
−1
 s
−1
) of the complexes were determined 
using standard methodology (by plotting the reciprocal longitudinal relaxation times of the complexes 
against their concentrations). Owing to the slow complex formation, the stability of the Gd
3+
 complexes was 
determined by promoting the partial to full dissociation of the complexes in batch samples (1 mM) covering 
the pH range 2.5–8.0 set with the use of a buffer cocktail consisting of 25 : 25 : 25 mM of piperazine 
(pip), N-methyl-piperazine (nmp) and N,N′-dimethyl-piperazine (dmp). In order to determine the time needed 
for equilibration (4 months), three representative samples with pH = 3.00, 4.94 and 7.05 were prepared and 
their relaxivities recorded as a function of time. The relaxivities of the batch samples were repeatedly 
measured one year later in order to confirm that the equilibrium was indeed attained. The equilibrium 
involving the Mn
2+
 ion was considerably faster as relaxivities of the batch samples prepared by mixing 
equimolar amounts of Mn
2+
 and dodpa
2−
 or Medodpa
2−
 ligands (2.5–2.5 mM each) and various amounts of 
acid (covering the pH range of 1.93–6.67 and 1.90–3.51 for the dodpa2− or Medodpa2− systems, respectively) 
became constant within 5 minutes from their preparation. The kinetic inertness of the [Gd(dodpa)]
+
 and 
[Gd(Medodpa)]
+
complexes was characterized by studying the acid catalyzed dissociation of the complexes 
under pseudo first order conditions (1 mM Gd
3+
 complex solutions were studied in the acid concentration 
range of 9.87–25.2 mM and 10.1–79.9 mM, respectively). The kinetic profiles obtained by recording the 
relaxivity as a function of time were fitted to eqn (9) using the Scientist™ program. In these calculations the 
relaxivities of the complex and the Gd
3+
 ion (at 25 °C and 20 MHz) were fixed to their values determined 
independently. 
X-ray crystallography 
X-ray diffraction data of [Cu(Medodpa)]·5H2O (1) were collected with a circular diffractometer X-Calibur-2 
CCD 4 (Oxford Diffraction), including a four circle goniometer (KM4) and a two dimensional CCD detector 
(SAPPHIRE 2). Three dimensional X-ray diffraction data were collected on an X-CALIBUR-2 CCD 4-circle 
diffractometer (Oxford Diffraction). Data reduction, including inter-frame scaling, Lorentz, polarization, 
empirical absorption and detector sensitivity corrections, was carried out using attached programs of Crysalis 
software
42
 (Oxford Diffraction). Complex scattering factors were taken from the program 
SHELX97
43
 running under the WinGX program system.
44
 The structure was solved by direct methods with 
SIR-97
45
 and refined by full-matrix least-squares on F
2
. X-ray diffraction data of 
Na[H4Medodpa](CF3COO)3·CF3COOH (2) were collected on a Bruker Kappa APEXII CCD diffractometer. 
Data were corrected for Lorentz and polarization effects and for absorption by semiempirical 
methods
46
 based on symmetry-equivalent reflections. Complex scattering factors were taken from the 
program SHELX97
43
running under the WinGX program system
44
 as implemented on a Pentium® computer. 
The structure was solved by direct methods using SHELXS97
43
 and refined
43
 by full-matrix least-squares 
on F
2
. All hydrogen atoms were included in calculated positions and refined in riding mode, except those of 
the disordered CF3COOH molecule present in crystals of 2, which were located in a difference electron-
density map and the torsion angle refined. Crystal data and details of data collection and refinement are 
summarized in Table 4. CCDC 1017211 and 1015477 contain the supplementary crystallographic data for 
this paper. 
 
 
 
Table 4. Crystal data and refinement details of [Cu(Medodpa)]·5H2O (1) and  
Na[H4Medodpa](CF3COO)3·CF3COOH (2). 
 
 1 2 
Formula C24H42CuN6O9 C32H37F12N6NaO12 
MW 622.18 948.66 
Crystal system Orthorhombic Monoclinic 
Space group P212121 P21/c 
T/K 300(2) 100(2) 
a/Å 10.2042(7) 20.412(2) 
b/Å 16.8211(11) 9.4077(10) 
c/Å 16.8403(11) 21.531(3) 
α/° 90 90 
β/° 90 101.241(6) 
γ/° 90 90 
V/Å
3
 2890.6(3) 4055.3(8) 
F(000) 1316 1944 
Z 4 4 
λ/Å(MoKα) 0.71073 0.71073 
D calc/g cm
−3
 1.43 1.554 
μ/mm−1 0.815 0.161 
θ Range/° 3.14 to 26.37 1.929 to 26.372 
R int 0.0952 0.0877 
Reflns measd 22 452 45 414 
Unique reflns 5901 8301 
Reflns obsd 3242 6136 
GOF on F
2
 0.817 1.036 
R 1
a
 0.0516 0.0626 
wR2 (all data)
b
 0.0907 0.1827 
Largest differences peak and hole/e Å
−3
 0.712/−0.319 0.794/−0.478 
 
a R 1 = ∑||Fo| − |Fc||/∑|Fo|. b wR2 = {∑[w(||Fo|
2
 − |Fc|
2
)
2]/∑[w(Fo
4
)]}
1/2
. 
 
 
Computational methods 
All calculations were performed employing the Gaussian 09 package (revision B.01).
47
 Full geometry 
optimizations of the [La3(dodpa)3(H2O)3]
3+
 system were performed in the gas phase at the HF level by using 
the quasirelativistic effective core potential (ECP) of Dolg et al. and the related [5s4p3d]-GTO valence basis 
set for the lanthanides,
48
 and the 3-21G basis set for C, H, N and O atoms. Although small, HF calculations 
employing this basis set in combination with the f-in-core ECP of Dolg were shown to provide molecular 
geometries of macrocyclic Ln
3+
 complexes in good agreement with the experimental structures observed by 
single-crystal X-ray diffraction studies.
49
 No symmetry constraints have been imposed during the 
optimizations. Due to the considerable computational effort involving the calculation of second derivatives 
the optimized geometries were not characterized using frequency analysis. Full geometry optimizations of 
the [Lu(Medodpa)]
+
 system were performed in aqueous solution employing DFT within the hybrid meta-
GGA approximation with the TPSSh exchange–correlation functional,50 in combination with the ECP of 
 
 
Dolg et al.
48
 for the lanthanide and the standard 6-31G(d) basis set for the ligand atoms. Solvent effects were 
included using the integral equation formalism of the polarizable continuum model (IEFPCM).
51
 The 
stationary points found on the potential energy surfaces as a result of the geometry optimizations have been 
tested to represent energy minima rather than saddle points via frequency analysis. Molecular volumes, 
defined as the volume inside a contour of 0.001 electron Bohr
−3
, were calculated at the TPSSh/6-31G(d) 
level using the volume = tight keyword in Gaussian 09. 
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